FLAG Therapeutics Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 2

Employees
  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2M

  • Investors
  • 1

FLAG Therapeutics General Information

Description

Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The company's therapies are based on two investigational product platforms that are Anti-angiogenic/Anti-tubulin (AA/AT) platform and Folate-target Anti-cancer (FTAC) platform that include multiple water-soluble small molecule compounds, enabling doctors to treat multiple cancer types including brain, lung, ovarian and pancreatic.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 9168 Wooden Road
  • Raleigh, NC 27617
  • United States
+1 (919) 000-0000

FLAG Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FLAG Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 01-Jul-2019 $2M 00.000 Completed Pre-Clinical Trials
4. Seed Round 09-Jan-2019 00.00 00.000 000.00 Completed Startup
3. Debt - General 21-Nov-2018 00000 00000 Completed Startup
2. Grant 01-Jan-2017 $1.5M $250K Completed Startup
1. Debt - General 06-Mar-2015 $250K $250K Completed Startup
To view FLAG Therapeutics’s complete valuation and funding history, request access »

FLAG Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.0 00.0 00 00.0 00.00
To view FLAG Therapeutics’s complete cap table history, request access »

FLAG Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Frank Sorgi Ph.D Founder, President & Chief Executive Officer
Jackie Walling Ph.D Chief Medical Officer
To view FLAG Therapeutics’s complete executive team members history, request access »

FLAG Therapeutics Board Members (1)

Name Representing Role Since
Frank Sorgi Ph.D FLAG Therapeutics Founder, President & Chief Executive Officer 000 0000
To view FLAG Therapeutics’s complete board members history, request access »

FLAG Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FLAG Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view FLAG Therapeutics’s complete investors history, request access »